Meta Platforms
META
Oracle
ORCL
Strategy
MSTR
4
Toll Brothers
TOL
5
MARA Holdings
MARA
US Stock MarketDetailed Quotes
CCCC C4 Therapeutics
- 1.740
- +0.110+6.75%
Close May 2 16:00 ET
- 1.700
- -0.040-2.30%
Post 20:01 ET
123.55MMarket Cap-1.14P/E (TTM)
1.790High1.650Low1.15MVolume1.650Open1.630Pre Close1.99MTurnover2.44%Turnover RatioLossP/E (Static)71.01MShares7.66052wk High0.57P/B81.77MFloat Cap1.08552wk Low--Dividend TTM46.99MShs Float51.210Historical High--Div YieldTTM8.59%Amplitude1.060Historical Low1.737Avg Price1Lot Size
C4 Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 39.01%-65.16M | 25.31%-17.93M | 21.41%-24.13M | 73.82%-4.97M | 45.30%-18.12M | -0.85%-106.84M | 17.57%-24.01M | -9.59%-30.71M | 14.41%-19M | -24.55%-33.13M |
| Net income from continuing operations | 20.51%-105.32M | 0.52%-34.57M | 8.77%-24.67M | 50.68%-17.72M | 18.46%-28.36M | -3.37%-132.49M | 6.54%-34.75M | 15.40%-27.04M | -31.04%-35.92M | -9.99%-34.78M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | --621K | --0 | ---- | ---- | ---- |
| Depreciation and amortization | -3.30%1.82M | 11.63%480K | -1.12%442K | -2.18%448K | -17.80%448K | 12.17%1.88M | -17.47%430K | 7.71%447K | 5.29%458K | 78.69%545K |
| Other non cash items | -3.22%6.43M | 4.21%1.58M | -0.36%1.65M | -2.01%1.71M | -13.74%1.49M | 0.48%6.64M | -9.58%1.52M | -1.96%1.65M | -7.38%1.75M | 26.84%1.73M |
| Change In working capital | 210.23%7.65M | 118.13%7.42M | 33.31%-9M | -37.41%5.87M | 153.97%3.36M | 58.65%-6.94M | 615.61%3.4M | -220.72%-13.5M | 265.40%9.38M | 0.37%-6.22M |
| -Change in receivables | 184.22%8.7M | 164.06%7.24M | -1,837.50%-9.17M | 2,586.20%12.43M | -290.37%-1.8M | -343.33%-10.33M | -75,433.33%-11.3M | 137.84%528K | -893.65%-500K | -76.04%945K |
| -Change in prepaid assets | -258.94%-4.33M | -102.12%-28K | 217.92%816K | -127.91%-446K | -1,037.75%-4.67M | 601.80%2.72M | 671.35%1.32M | 54.02%-692K | 13.09%1.6M | 61.17%498K |
| -Change in payables and accrued expense | -187.22%-1.39M | -29.00%3.8M | 403.31%4.76M | -252.60%-2.47M | -96.45%-7.48M | -9.20%1.59M | 231.13%5.35M | -300.00%-1.57M | -62.13%1.62M | 22.57%-3.81M |
| -Change in other current liabilities | -11.16%-5.22M | -10.95%-1.34M | -11.01%-1.32M | -10.98%-1.3M | -11.74%-1.26M | -826.04%-4.7M | -11.46%-1.21M | -176.38%-1.19M | 8.70%-1.18M | -469.74%-1.12M |
| -Change in other working capital | 162.04%9.88M | -124.34%-2.25M | 61.38%-4.08M | -129.95%-2.35M | 779.71%18.56M | 116.65%3.77M | 769.49%9.24M | -100.68%-10.57M | 177.40%7.84M | 53.57%-2.73M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 39.01%-65.16M | 25.31%-17.93M | 21.41%-24.13M | 73.82%-4.97M | 45.30%-18.12M | -0.85%-106.84M | 17.57%-24.01M | -9.59%-30.71M | 14.41%-19M | -24.55%-33.13M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -132.38%-51.27M | -57.21%13.67M | -99.72%162K | -177.28%-11.71M | -199.75%-53.4M | 171.04%158.35M | 244.09%31.95M | 189.87%57.73M | -54.41%15.15M | 1,436.94%53.53M |
| Net PPE purchase and sale | 89.46%-180K | 102.55%4K | 102.17%13K | 45.58%-197K | --0 | 68.92%-1.71M | 89.46%-157K | 81.85%-600K | 31.57%-362K | -242.44%-589K |
| Net investment purchase and sale | -131.92%-51.09M | -57.43%13.67M | -99.74%149K | -174.20%-11.51M | -198.66%-53.4M | 150.41%160.06M | 197.96%32.1M | 151.20%58.33M | -54.05%15.51M | 1,512.32%54.12M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -132.38%-51.27M | -57.21%13.67M | -99.72%162K | -177.28%-11.71M | -199.75%-53.4M | 171.04%158.35M | 244.09%31.95M | 189.87%57.73M | -54.41%15.15M | 1,436.94%53.53M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -0.34%45.34M | -99.81%112K | 197.70%10.51M | 118.10%135K | 5,155.99%34.58M | 3,865.91%45.49M | 122,606.38%57.67M | -3,078.67%-10.75M | -388.03%-746K | -242.50%-684K |
| Net issuance payments of debt | --0 | --0 | --0 | --0 | --0 | ---12.5M | --0 | ---11M | ---750K | ---750K |
| Net common stock issuance | -23.26%44.18M | --0 | 63,825.00%10.2M | --0 | 36,248.94%33.98M | --57.56M | --57.67M | ---16K | --0 | ---94K |
| Proceeds from stock option exercised by employees | 1,241.38%778K | --111K | --13K | 6,650.00%135K | 826.79%519K | -92.54%58K | --0 | --0 | -99.23%2K | -78.46%56K |
| Net other financing activities | 3.80%382K | 200.00%1K | 12.93%297K | --0 | -19.23%84K | -0.54%368K | ---1K | 75.33%263K | --2K | -52.73%104K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -0.34%45.34M | -99.81%112K | 197.70%10.51M | 118.10%135K | 5,155.99%34.58M | 3,865.91%45.49M | 122,606.38%57.67M | -3,078.67%-10.75M | -388.03%-746K | -242.50%-684K |
| Net cash flow | ||||||||||
| Beginning cash position | 293.65%130.03M | -2.07%63.09M | 58.96%76.56M | 76.48%93.1M | 293.65%130.03M | -58.40%33.03M | 21.95%64.43M | -20.50%48.16M | 7.05%52.76M | -58.40%33.03M |
| Current changes in cash | -173.29%-71.09M | -106.33%-4.15M | -182.79%-13.47M | -260.07%-16.55M | -287.26%-36.93M | 309.19%97M | 431.40%65.61M | 310.01%16.27M | -140.69%-4.6M | 165.48%19.72M |
| End cash Position | -54.67%58.94M | -54.67%58.94M | -2.07%63.09M | 58.96%76.56M | 76.48%93.1M | 293.65%130.03M | 293.65%130.03M | 21.95%64.43M | -20.50%48.16M | 7.05%52.76M |
| Free cash flow | 39.81%-65.34M | 25.81%-17.93M | 22.96%-24.12M | 73.29%-5.17M | 46.26%-18.12M | 2.59%-108.55M | 21.07%-24.17M | 0.06%-31.31M | 14.81%-19.36M | -25.95%-33.71M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025